Show Summary Details
Page of

Pharmacological therapy of hyperglycaemia in type 2 diabetes mellitus 

Pharmacological therapy of hyperglycaemia in type 2 diabetes mellitus
Chapter:
Pharmacological therapy of hyperglycaemia in type 2 diabetes mellitus
Author(s):

Clifford J. Bailey

and Melanie J. Davies

DOI:
10.1093/med/9780199235292.003.1373
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2016. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 09 December 2019

The management of type 2 diabetes is complex, due to the diverse, variable, and progressive nature of its pathogenesis, clinical complications, and societal impact (Box 13.4.2.1). Care plans need to be individualized, flexible, and realistic, with provision for patient education and empowerment to enable optimal benefit from the guidance and interventions offered by health care professionals. Relief of acute symptoms and attention to long-term complications and co-morbidities often preoccupy and sometimes overwhelm the treatment process. However, early and sustained remediation of endocrine and metabolic disturbances, plus containment of modifiable cardiovascular risk factors, prevent the onset and limit the severity of chronic pathology. Glycaemic control is a crucial part of the treatment process, and serves as the conventional indicator of metabolic status. This chapter will focus on the treatment of hyperglycaemia, and, particularly, the role of pharmacological therapies.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.